Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies

Creative Commons License

Ozturk O., DEMİRCİ DOS SANTOS DUARTE S., BALABAN H. Y., ŞİMŞEK H., Sener B.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.5, ss.1697-1703, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 5
  • Basım Tarihi: 2022
  • Doi Numarası: 10.55730/1300-0144.5512
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1697-1703
  • Anahtar Kelimeler: Autoimmune hepatitis, primary biliary cholangitis, immunofluorescence test, immunoblot test, PRIMARY BILIARY-CIRRHOSIS, AUTOIMMUNE LIVER-DISEASE, CLINICAL-SIGNIFICANCE, AUTOANTIBODIES, HEPATITIS, DIAGNOSIS, ANTIGENS, SEROLOGY, ASSAY, SERA
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background/aim: Antinuclear antibodies (ANA) and antimitochondrial antibodies (AMA) have essential markers for the diagnosis of autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). These autoantibodies are detecting different laboratory methods. In this study, we studied the diagnostic performance of used methods in detecting ANA and AMA.